Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

Daihan Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	170,814	154,056	163,170	183,600	172,200	197,700
Market Cap Growth	12.60%	-5.59%	-11.13%	6.62%	-12.90%	4.11%
Enterprise Value	84,613	80,167	60,093	96,028	117,564	155,174
Last Close Price	29050.00	25420.50	26008.24	27909.78	25618.96	29002.77
PE Ratio	5.41	4.56	5.74	7.36	7.60	11.38
PS Ratio	0.82	0.75	0.83	1.00	1.00	1.19
PB Ratio	0.58	0.56	0.66	0.82	0.85	1.09
P/TBV Ratio	0.58	0.56	0.66	0.82	0.85	1.09
P/FCF Ratio	40.60	7.76	9.28	9.01	5.99	6.99
P/OCF Ratio	5.27	4.32	4.20	6.33	4.24	5.88
EV/Sales Ratio	0.40	0.39	0.31	0.52	0.69	0.93
EV/EBITDA Ratio	1.90	1.77	1.35	2.28	2.90	3.76
EV/EBIT Ratio	2.33	2.11	1.68	2.91	4.04	5.18
EV/FCF Ratio	20.11	4.04	3.42	4.71	4.09	5.49
Debt / Equity Ratio	0	0	-	0.03	0.12	0.16
Debt / EBITDA Ratio	0.00	0.00	-	0.15	0.58	0.70
Debt / FCF Ratio	0.01	0.00	-	0.32	0.82	1.02
Asset Turnover	0.64	0.66	0.69	0.67	0.65	0.66
Inventory Turnover	4.68	5.36	5.38	5.46	5.22	5.03
Quick Ratio	2.76	2.58	3.28	3.04	2.72	2.47
Current Ratio	3.55	3.22	3.87	3.65	3.20	3.10
Return on Equity (ROE)	11.24%	12.89%	12.01%	11.66%	11.79%	9.97%
Return on Assets (ROA)	6.91%	7.69%	7.83%	7.50%	6.91%	7.49%
Return on Invested Capital (ROIC)	14.76%	17.74%	19.93%	18.62%	15.86%	16.06%
Return on Capital Employed (ROCE)	12.10%	13.50%	14.20%	14.10%	12.80%	14.00%
Earnings Yield	18.47%	21.91%	17.42%	13.59%	13.16%	8.79%
FCF Yield	2.46%	12.88%	10.77%	11.10%	16.71%	14.30%
Payout Ratio	16.46%	12.82%	13.20%	8.45%	9.30%	12.13%
Buyback Yield / Dilution	-	-	1.75%	0.25%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.